STEMI直接PCI后的室性心律失常
该队列研究纳入2015年1月1日至2018年12月31日美国国家心血管数据注册胸痛-心梗注册中≥18岁、接受直接PCI的STEMI患者174126例(814个中心),其中无并发症STEMI 99905例(57.4%,807个中心)。直接PCI后室速或室颤发生率为8.9%,晚期室速或室颤(PCI后≥1天)为2.4%;无并发症STEMI队列晚期事件为1.7%。晚期室速或室颤合并心脏骤停总体0.4%、无并发症STEMI 0.1%。LVEF是与晚期室速或室颤合并心脏骤停最显著相关的因素(LVEF≤40%时每降低5单位AOR 1.67,95%CI 1.54-1.85);晚期室速或室颤与院内死亡 odds 升高相关(总体AOR 6.40,95%CI 5.63-7.29;无并发症STEMI AOR 8.74,95%CI 6.53-11.70)。作者认为该信息可能有助于确定STEMI后最佳出院时机。
要点
- 直接PCI后晚期室速或室颤(PCI后≥1天)总体风险2.4%,无并发症STEMI队列为1.7%。
- 晚期室速或室颤合并心脏骤停总体674例(0.4%),无并发症STEMI 117例(0.1%)。
- LVEF是与晚期室速或室颤合并心脏骤停最显著相关的因素,LVEF≤40%时每降低5单位AOR 1.67(95%CI 1.54-1.85)。
- 晚期室速或室颤与院内死亡 odds 升高相关:总体AOR 6.40(95%CI 5.63-7.29),无并发症STEMI AOR 8.74(95%CI 6.53-11.70)。
- 作者认为该信息可能有助于确定STEMI后最佳出院时机。
适用人群与场景
- 年龄≥18岁、2015年1月1日至2018年12月31日接受直接PCI的STEMI患者,来源于美国国家心血管数据注册胸痛-心梗注册。
- 无并发症STEMI队列:无既往心肌梗死或心力衰竭、收缩压<90 mm Hg、心源性休克、心脏骤停、再梗死或左心室射血分数(LVEF)<40%。
诊断标准与关键阈值
- 晚期室速:STEMI住院期间、PCI后≥1天出现≥7个心搏的室速连发。
- 晚期室颤:PCI后≥1天出现任何一次室颤发作。
红旗征与不能漏的情况
- 晚期室速或室颤合并心脏骤停:总体674例(0.4%),无并发症STEMI 117例(0.1%)。
- 晚期室速或室颤与院内死亡 odds 升高相关:总体AOR 6.40(95%CI 5.63-7.29),无并发症STEMI AOR 8.74(95%CI 6.53-11.70)。
研究设计与关键结果
- 研究类型:队列研究;样本量174126例,814个中心;人群为接受直接PCI的STEMI患者;主要终点为晚期室速或室颤。
- 直接PCI后室速或室颤15460例(8.9%),晚期室速或室颤4156例(2.4%);无并发症STEMI 99905例(57.4%,807个中心),晚期室速或室颤风险1.7%。
- 晚期室速或室颤总体患者中位年龄63岁(IQR 55-73),男性75.5%;无并发症STEMI晚期室速或室颤患者中位年龄60岁(IQR 53-69),男性77.7%。
- 晚期室速或室颤患者中位住院时间:总体3天(IQR 2-7天),无并发症STEMI 3天(IQR 2-4天)。
- LVEF是与晚期室速或室颤合并心脏骤停最显著相关的因素,LVEF≤40%时每降低5单位AOR 1.67(95%CI 1.54-1.85)。
证据类型、等级与局限
- 证据类型:队列研究(美国国家心血管数据注册胸痛-心梗注册)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,晚期室速或室颤总体少见、合并心脏骤停罕见(尤其无并发症STEMI),该信息可能有助于确定STEMI后最佳出院时机。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Currently, mortality risk for patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) with an uncomplicated postprocedure course is low. Less is known regarding the risk of in-hospital ventricular tachycardia (VT) and ventricular fibrillation (VF).
OBJECTIVE: To evaluate the risk of late VT and VF after primary PCI for STEMI.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study included adults aged 18 years or older with STEMI treated with primary PCI between January 1, 2015, and December 31, 2018, identified in the US National Cardiovascular Data Registry Chest Pain-MI Registry. Data were analyzed from April to December 2020.
MAIN OUTCOMES AND MEASURES: Multivariable logistic regression was used to evaluate the risk of late VT (≥7 beat run of VT during STEMI hospitalization ≥1 day after PCI) or VF (any episode of VF≥1 day after PCI) associated with cardiac arrest and associations between late VT or VF and in-hospital mortality in the overall cohort and a cohort with uncomplicated STEMI without prior myocardial infarction or heart failure, systolic blood pressure less than 90 mm Hg, cardiogenic shock, cardiac arrest, reinfarction, or left ventricular ejection fraction (LVEF) less than 40%.
RESULTS: A total of 174 126 eligible patients with STEMI were treated with primary PCI at 814 sites in the study; 15 460 (8.9%) had VT or VF after primary PCI, and 4156 (2.4%) had late VT or VF. Among the eligible patients, 99 905 (57.4%) at 807 sites had uncomplicated STEMI. The median age for patients with late VT or VF overall was 63 years (IQR, 55-73 years), and 75.5% were men; the median age for patients with late VT or VF with uncomplicated STEMI was 60 years (IQR, 53-69 years), and 77.7% were men. The median length of stay was 3 days (IQR, 2-7 days) for the overall cohort with late VT or VF and 3 days (IQR, 2-4 days) for the cohort with uncomplicated STEMI with late VT or VF. The risk of late VT or VF was 2.4% (overall) and 1.7% (uncomplicated STEMI). Late VT or VF with cardiac arrest occurred in 674 patients overall (0.4%) and in 117 with uncomplicated STEMI (0.1%). LVEF was the most significant factor associated with late VT or VF with cardiac arrest (adjusted odds ratio [AOR] for every 5-unit decrease ≤40%: 1.67; 95% CI, 1.54-1.85). Late VT or VF events were associated with increased odds of in-hospital mortality in the overall cohort (AOR, 6.40; 95% CI, 5.63-7.29) and the cohort with uncomplicated STEMI (AOR, 8.74; 95% CI, 6.53-11.70).
CONCLUSIONS AND RELEVANCE: In this study, a small proportion of patients with STEMI treated with primary PCI had late VT or VF. However, late VT or VF with cardiac arrest was rare, particularly in the cohort with uncomplicated STEMI. This information may be useful when determining the optimal timing for hospital discharge after STEMI.
参考来源
- Rymer JA, Wegermann ZK, Wang TY, et al. Ventricular Arrhythmias After Primary Percutaneous Coronary Intervention for STEMI. JAMA Netw Open. 2024. PMID: 38717772. doi:10.1001/jamanetworkopen.2024.10288
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。